STOCKWATCH
·
Commodity Chemicals
Deals13 May 2024, 10:13 pm

TCM LTD. Enteres MOU with Biogenix Inc. for Contract Manufacture of Diagnostic Reagents

AI Summary

TCM LTD. has entered into a Memorandum of Understanding (MOU) with Biogenix Inc. for the contract manufacture of various reagents used in diagnostic laboratories. Biogenix, a company with expertise and statutory licenses in reagent manufacturing, will produce reagents for TCM under their brand and packing as per TCM's specifications.

Key Highlights

  • TCM has entered into an MOU with Biogenix for contract manufacture of diagnostic reagents.
  • Biogenix holds necessary licenses and expertise in reagent manufacturing.
  • TCM will rely on Biogenix's competency and expertise for quality.
  • Biogenix will provide manufacturing, storage, packing, and delivery services.
  • There is no shareholding or special rights mentioned in the agreement.
TCMLMTD
Commodity Chemicals
TCM LTD.

Price Impact